Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Organisation › Details

Selvita (Group)

Selvita is a preclinical Contract Research Organization providing multidisciplinary support in resolving the unique challenges of research within area of drug discovery, regulatory studies, as well as research and development. The Company was established in 2007 and currently employs over 550 professionals, of which over 1/3 hold a PhD title. Selvita is headquartered in Krakow, Poland, with a second research site in Poznan, Poland and international offices located in Cambridge, MA and South San Francisco, in the U.S., as well as in Cambridge, UK. Selvita is a major shareholder in Ardigen – bioinformatics company harnessing advanced Artificial Intelligence methods for novel precision medicine. Selvita has a proven track record of successfully completed projects and customers in 40 countries. The majority of Company revenues come from pharma, biotech, chemical and agrochemical companies from the U.S. and Europe. Selvita is listed on the Warsaw Stock Exchange (WSE:SLV). *


Period Start 2007-01-01 established
Products Industry drug discovery services
  Industry 2 chemical services
Persons Person Przewiezlikowski, Pawel (Selvita 201309 CEO + Co-Founder)
  Person 2 Sieczkowski, Boguslaw (Selvita 201405 CFO + Co-Founder + key shareholder)
Region Region Kraków
  Country Poland
  Street 14 ul. Bobrzynskiego
Park Life Science
  City 31444 Kraków
  Tel +48-12-297-4700
    Address record changed: 2020-12-02
Basic data Employees E: 501 to 1,000 (2020-11-23)
  Currency EUR
  Annual sales 13,319,000 (revenues, total, consolidated (2015) 2015-12-31)
  Profit 1,490,000 (2015-12-31)
  Cash 6,760,000 (2015-12-31)
    * Document for �About Section�: Galapagos N.V.. (11/23/20). "Press Release: Selvita to Acquire Fidelta from Galapagos". Mechelen & Krakow.
Record changed: 2020-11-27


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Selvita (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top